Cannabinoids for prophylactic treatment of involuntary weight loss
EA032344B1
Use of a ready-to-use formulation comprising a solution of esmolol hydrochloride and method of treatment
EP2796139A1
Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias
NZ609356A
Fast disintegrating compositions comprising nabilone and randomly methylated beta cyclodextrin
ME02118B
Novel composition for treatment of essential thrombocythemia
WO2010063824A1
Novel composition for treatment of essential thrombocythemia
WO2009079679A2
Pharmaceutical composition for the parenteral administration of ultrashort-effective beta-adrenoreceptor antagonists
ATA2732004A
Preparation of anagrelide hydrochloride, useful for thrombocyte suppression, using 2,3-dichlorobenzaldehyde as starting material, avoids use of toxic reagents
EP1417962A1
Method for the manufacture of a medicament comprising esmolol
